Journal Logo

April 2001 - Volume 29 - Issue 4
pp: 703-919

Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection

Furue, Shingo; Mikawa, Katsuya; Nishina, Kahoru; More

Critical Care Medicine. 29(4):719-727, April 2001.

Increased incidence of sepsis and altered monocyte functions in severely injured type A− glucose-6-phosphate dehydrogenase-deficient African American trauma patients

Spolarics, Zoltán; Siddiqi, Muhammad; Siegel, John H.; More

Critical Care Medicine. 29(4):728-736, April 2001.

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

Reinhart, Konrad; Menges, Thilo; Gardlund, Bengt; More

Critical Care Medicine. 29(4):765-769, April 2001.

Modulation of soluble phases of endothelial/leukocyte adhesion molecule 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 with interleukin-1β after experimental endotoxic challenge

Téllez Gil, Luis; Mansilla Roselló, Alfonso; Collado Torres, Antonia; More

Critical Care Medicine. 29(4):776-781, April 2001.

Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients

Lyons, Jeremy; Rauh-Pfeiffer, Astrid; Ming-Yu, Yong; More

Critical Care Medicine. 29(4):870-877, April 2001.

Workshop executive summary report: Postresuscitative and initial utility in life-saving efforts (PULSE), June 29–30, 2000, Lansdowne Resort and Conference Center, Leesburg, VA

Harry Weil, Max; Becker, Lance; Budinger, Thomas; More

Critical Care Medicine. 29(4):878-879, April 2001.

New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome

Ishizaka, Akitoshi; Watanabe, Masazumi; Yamashita, Tetsuji; More

Critical Care Medicine. 29(4):896-898, April 2001.